B12: The Deficiency That Hides in Plain Sight—and Who's Really at Risk

A Nutrient Problem That Doesn't Announce Itself

Most nutritional deficiencies follow a predictable narrative: a particular group avoids a particular food, and the shortfall is obvious. Vitamin B12 refuses to cooperate with that tidy story. It affects meat-eaters and plant-based eaters alike. It surfaces in people who appear to eat well, exercise regularly, and take a daily multivitamin. And because its early symptoms—fatigue, mild cognitive slowing, occasional tingling in the extremities—overlap with dozens of other conditions, it can linger undetected for years before triggering anything a physician would flag as urgent.

That invisibility is precisely what makes B12 one of the more consequential nutritional blind spots in American health today.

Why Plant-Based Eaters Are the Most Discussed—But Not the Only—Group at Risk

The connection between veganism and B12 insufficiency is well-established and worth stating plainly: B12 is found almost exclusively in animal-derived foods. Meat, fish, dairy, and eggs are its primary dietary sources. Someone who eliminates all of these without supplementing will, over time, deplete their stores. The body can hold reserves for two to five years, which is why new vegans often feel fine initially and then encounter problems they don't immediately connect to their diet.

Vegetarians who consume dairy and eggs are somewhat better protected but still at elevated risk compared to omnivores, particularly if their intake of those foods is modest.

However, focusing exclusively on plant-based diets misses a large portion of people who are quietly running low. According to data from the Framingham Offspring Study, nearly 40 percent of American adults between the ages of 26 and 83 had plasma B12 levels in a range considered low-normal or deficient—and the distribution across dietary patterns was more even than most people expect.

The Absorption Problem: When Diet Isn't the Issue

For a meaningful segment of the population, the deficiency has nothing to do with dietary choices. It comes down to absorption.

B12 is one of the more complex nutrients to absorb. In the stomach, it must bind to a protein called intrinsic factor, produced by specialized cells in the gastric lining, before it can be taken up in the small intestine. When anything disrupts this pathway—whether disease, medication, or age-related changes to the stomach—dietary B12 becomes largely unavailable regardless of how much is consumed.

Older adults are disproportionately affected. Atrophic gastritis, a condition involving reduced stomach acid production, becomes increasingly common after age 50 and is estimated to affect 10 to 30 percent of adults in that age bracket. Without adequate stomach acid, the initial step of freeing B12 from food proteins cannot occur efficiently. This is why clinical guidelines specifically recommend that adults over 50 obtain B12 from supplements or fortified foods—forms that bypass the need for stomach acid in the early extraction process.

Metformin users represent another underappreciated group. Metformin, one of the most widely prescribed medications in the United States for type 2 diabetes management, has been shown in multiple studies to reduce B12 absorption over time. The mechanism involves interference with calcium-dependent membrane action in the ileum. Long-term users who are not monitoring their B12 levels may be accumulating a deficiency while managing another condition entirely.

Proton pump inhibitors (PPIs), prescribed for acid reflux and related conditions, carry a similar concern when used chronically. By reducing stomach acid output, they impair the same early-stage extraction process affected by atrophic gastritis.

Individuals with a history of gastrointestinal surgery, including gastric bypass procedures, may have reduced intrinsic factor production or reduced absorptive surface area, placing them at significant risk.

Why Standard Blood Tests Often Fall Short

Serum B12 testing is the most common diagnostic tool, but it has a well-documented limitation: it measures total circulating B12, including forms that are bound to carrier proteins and functionally inactive. A person can have a serum B12 reading within the reference range and still have insufficient active B12 at the cellular level.

More sensitive markers exist. Methylmalonic acid (MMA) and homocysteine are metabolic byproducts that accumulate when B12-dependent enzymatic reactions slow down. Elevated MMA in particular is considered a more reliable indicator of functional B12 deficiency than serum B12 alone. Holotranscobalamin, which measures only the active fraction of circulating B12, is another emerging marker—though it is not yet universally available through standard lab panels.

If you have risk factors for B12 deficiency but your serum result appears normal, it is worth asking your physician about these additional tests. Marginal deficiency caught early is far easier to address than the neurological complications that can develop with prolonged insufficiency.

The Neurological and Metabolic Stakes

B12 is not a peripheral nutrient. It is required for the synthesis of myelin, the protective sheath surrounding nerve fibers, and for the production of DNA. It also participates in the conversion of homocysteine to methionine—a reaction with significant implications for cardiovascular health and neurological function.

When B12 falls short over an extended period, the consequences can include peripheral neuropathy (numbness, tingling, or burning sensations in the hands and feet), subacute combined degeneration of the spinal cord in severe cases, megaloblastic anemia, cognitive impairment, and mood disturbances including depression. Some of these effects, particularly neurological damage, may not be fully reversible even after B12 is restored—which makes early identification genuinely important rather than merely precautionary.

Cyanocobalamin vs. Methylcobalamin: What the Evidence Actually Supports

Walk through the supplement aisle at any health retailer and you will encounter both cyanocobalamin and methylcobalamin, often with marketing language suggesting the latter is significantly superior. The reality is more nuanced.

Cyanocobalamin is the synthetic form used in most clinical studies and is highly stable, well-absorbed, and cost-effective. The body converts it to active forms (methylcobalamin and adenosylcobalamin) as needed. It remains the form used in most fortified foods and many physician-recommended protocols.

Methylcobalamin is one of the two bioactive forms of B12 and does not require conversion. Some practitioners prefer it for patients with certain genetic variants affecting methylation pathways (notably MTHFR polymorphisms), though the clinical evidence supporting methylcobalamin's superiority in the general population remains limited rather than conclusive.

For most people, cyanocobalamin at adequate doses is a well-supported, evidence-consistent choice. For individuals with specific methylation concerns or those who prefer to skip the conversion step, methylcobalamin is a reasonable alternative. What matters most is consistent supplementation at a meaningful dose—not the form selected based on premium marketing.

High-dose oral supplementation (1,000 mcg daily) has been shown to be effective even in individuals with absorption impairments, because at high concentrations, a small percentage of B12 is absorbed passively through the intestinal lining without requiring intrinsic factor. This makes oral supplementation a viable option for many people who might otherwise assume they need injections.

A Practical Framework for Assessing Your Own Risk

Rather than waiting for symptoms to become disruptive, consider whether any of the following apply to you: a vegan or strict vegetarian diet, age over 50, long-term use of metformin or proton pump inhibitors, a history of gastrointestinal surgery, or a diagnosis of Crohn's disease or celiac disease. Each of these factors meaningfully elevates your likelihood of suboptimal B12 status.

At Dr. Zoh Wellness, the approach to nutritional support begins with understanding the science behind who needs what—and why. B12 is not a supplement that benefits everyone equally, but for those in higher-risk categories, it is one of the more impactful, well-researched, and accessible interventions available in nutritional medicine today.